Overview

Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This research study is being done to gather information about how to do further clinical studies using AZD3355 as an add-on treatment to proton pump inhibitors (PPI).
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Lesogaberan